A randomized clinical trial evaluating the efficacy and safety of Jesners solution against 88% Phenol: In the treatment of Alopecia Areata. - Nil

Dr Rakesh Tilak raj0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

研究概览

暂无简介。

•1.who has not received any treatment during previous 2 months before commencing of the study.
•2.Patients with minimum of two patches; ranging in circumference between 3cm to 10 cm.
•3.Patients with patchy patches of stable AA over the scalp
•4.Patients willing to be part of the study after informed consent.

•1.Patients treated with any other topical agent or immunosuppressive drugs.
•2.Patients with scarring alopecia and scalp condition affecting the outcomes.
•3.Patients who were on any allopathic or homeopathic treatment.
•4.Patients with psychiatric medications and unrealistic expectations.
•5.Pregnant and lactating mothers.
•6.Patients with a history of keloid and hypertrophic scars.
•7.Patient with any systemic disease (Cardiac, Renal, Hepatic, HIV, etc).
•8.Patient with history of drug abuse.
•9.Patient with collagen vascular disorder and auto-immune.
•10.Patients with alopecia totalis and universalis.
•11.Unwilling patients.
•12.Other causes of alopecia like Androgenic alopecia, Diffuse telogen effluvium

发起方

Dr Rakesh Tilak raj